Biodesix (NasdaqGM:BDSX) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Company ParticipantsChris Brinzey - PartnerRobin Harper Cowie - CFOScott Hutton - CEOWilliam Ruby - Equity Research AssociateConference Call ParticipantsAndrew Brackmann - Equity Research AnalystJohn Wilkin - Equity Research Analyst of Diagnostics and Life Science ToolsKyle Mikson - Managing Director and Senior Research AnalystThomas Flaten - Senior Research AnalystOperatorStanding by. Welcome to the Biodesix fourth quarter 2025 ea ...

Biodesix (NasdaqGM:BDSX) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Speaker4Standing by. Welcome to the Biodesix 4th quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 agai ...